Longer persistence seen with Upadacitinib versus tumor necrosis factor inhibitors in rheumatoid arthritis

Medical Xpress

Patients with rheumatoid arthritis (RA) have longer persistence with upadacitinib than tumor necrosis factor inhibitors (TNFi), according to a study published online June 23 in Rheumatology. ...

전문 보기

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

Longer persistence seen with Upadacitinib versus tumor necrosis factor inhibitors in rheumatoid arthritis

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

Sea stars offer rare view of how embryonic tubes become complex organs

Identifying the healing powers of sacred moments in health care

Bringing rice back to Hawaiʻi: Japanese cultivars yield high-quality grains in just three months

Medical Xpress의 다른 기사

How skimping on sleep leads to weight gain

Modest sleep loss linked to weight gain in adults with high cardiometabolic risk

Pandemic onset stalled reduction of benzodiazepine use among older Americans, says study